Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Unresectable Hepatocellular Carcinoma 1

Interventions

Therapeutics 1Immunotherapy 1Bumetanide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Unresectable Hepatocellular Carcinoma × Bumetanide × Clear all
NCT03107416 2026-05-05

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
30 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡